Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid vs Slow Weaning of Morphine or Methadone for Neonatal Opioid Withdrawal Syndrome
NCT04214834Phase 3Active, not recruiting
- Sponsor
- ACT NOW Program
- Start
- Sep 2020
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of morphine, methadone in neonatal opioid withdrawal syndrome (NOWS), sponsored by ACT NOW Program. Started Sep 2020; status: active, not recruiting.
02
Drugs
morphinemethadone
03
Conditions
neonatal opioid withdrawal syndrome (NOWS)
Beyond the preview
Go deeper on NCT04214834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214834.